Pyruvate Kinase (PK) Deficiency presents as a chronic, intermittent, hemolytic anemia. The disorder has a high variability of age of onset and severity of clinical signs. The age of onset of clinical signs varies from six months to five years of age. Clinical signs of the disorder are highly variable but may include lethargy, weakness, diarrhea, pale mucous membranes, anorexia, poor coat quality, weight loss, icterus (jaundice), splenomegaly, and ascites in severe cases. The severity of clinical signs also varies greatly with some cats maintaining adequate quality of life and others requiring euthanasia. The disorder has been reported in multiple cat breeds.

Therapy is limited to symptomatic treatments and general supportive care. Some cats are able to maintain an adequate quality of life while others require euthanasia.

There are many responsibilities to consider when breeding cats. Regardless of test results it is important that your cat is in good general health and that you are in a position to care for the kittens if new responsible owners are not found. For first time or novice breeders, advice can be found at most cat registry websites.

This disease is autosomal recessive meaning that two copies of the mutation are needed for disease signs to be shown. A carrier cat with one copy of the Pyruvate Kinase Deficiency mutation can be safely bred with a clear cat with no copies of the Pyruvate Kinase Deficiency mutation. About half of the kittens will have one copy (carriers) and half will have no copies of the Pyruvate Kinase Deficiency mutation. Kittens in a litter which is expected to contain carriers should be tested prior to breeding. Carrier to carrier matings are not advised as the resulting litter may contain affected kittens. Please note: It is possible that disease signs similar to the ones caused by the Pyruvate Kinase Deficiency mutation could develop due to a different genetic or clinical cause.